Search
for
Sort by
Research 421–450 of 1000+
- Cantú syndrome with coexisting familial pituitary adenoma
- A CLINICAL STUDY OF CUTANEOUS MANIFESTATIONS IN PATIENTS WITH THYROID DISORDERS
- Acne and acneiform eruptions
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- American Society for Laser Medicine and Surgery - 2018 Late-Breaking Abstracts
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- Iatrogenic Cushing’s syndrome post intralesional triamcinolone acetonide in Oral submucous fibrosis: 2 case reports
- Skin Disorders in Athletes: Professional and Recreational Sports
- 14 Rhytidectomy
- A Clinico-Epidemiological Study of Acne in Adults
- Australasian Society for Dermatology Research Meeting, May 2007
- Cutaneous signals of immune system disease
- The eosinophilia-myalgia syndrome
- Pathophysiology of the burn scar
- Frontal Fibrosing Alopecia Mimicking Alopecia Syphilitica
- Recovery of Transplanted Eyebrow From Radiation-Induced Anagen Effluvium
- Late Management of Burns
- AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY, INC.
- Studies of normal moult and of artifically induced regeneration of pelage in peromyscus
- ACNE
- Generalized Hypertrichosis Due to Topical Minoxidil
- Update on nail disorders
- Regenerative Medicine of Epidermal Structures
- Before & beyond the pain – Allostatic load, central sensitivity and their role in health and function
- The pink tax: gender-based cost disparities of topical minoxidil
- P378: Expanding the phenotype of hyper-IgE syndrome: Heterozygous VUS in IL6ST with elevated serum IgE and isolated abscesses
- Case 1: Intractable Rash in a 7-month-old Boy
- Reversible Alopecia with Localized Scalp Necrosis After Accidental Embolization of the Parietal Artery with Hyaluronic Acid
- Referee report. For: Comparison between Tazarotene 0.05% gel and Adapelene 0.1% gel in acne patients [version 1; peer review: 1 approved with reservations]